Page 177 - Haematologica August 2018

Dexamethasone promotes tolerance to factor VIII
31. Platt N, da Silva RP, Gordon S. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol. 1998;8(9):365-372.
32. Rogers NJ, Lees MJ, Gabriel L, et al. A defect in marco expression contributes to systemic lupus erythematosus development via fail- ure to clear apoptotic cells. J Immunol. 2009; 182(4):1982-1990.
33. Youm Y-H, Yang H, Amin R, Smith SR, Leff T, Dixit VD. Thiazolidinedione treatment and constitutive-PPAR activation induces ectopic adipogenesis and promotes age- related thymic involution. Aging Cell. 2010;9(4):478-489.
34. Lannes-Vieira J, Dardenne M, Savino W. Extracellular matrix components of the mouse thymus microenvironment: ontoge- netic studies and modulation by glucocorti- coid hormones. J Histochem Cytochem. 1991;39(11):1539-1546.
35. Gameiro J, Nagib P, Verinaud L. The thymus microenvironment in regulating thymocyte differentiation. Cell Adh Migr. 2010;4(3):382-390.
36. Oliveira VG, Agua-Doce A, Curotto de Lafaille MA, Lafaille JJ, Graca L. Adjuvant facilitates tolerance induction to factor VIII in hemophilic mice through a Foxp3-inde- pendent mechanism that relies on IL-10. Blood. 2013;121(19):3936-3945.
37. Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP. Blockade of CD40/CD40 ligand interactions prevents
induction of factor VIII inhibitors in hemo- philic mice but does not induce lasting immune tolerance. Thromb Haemost. 2001;86(6):1345-1352.
38. Liu CL, Ye P, Lin J, Djukovic D, Miao CH. Long-term tolerance to factor VIII is achieved by administration of interleukin- 2/interleukin-2 monoclonal antibody com- plexes and low dosages of factor VIII. J Thromb Haemost. 2014;12(6):921-931.
39. Duggan DE, Yeh KC, Matalia N, Ditzler CA, McMahon FG. Bioavailability of oral dex- amethasone. Clin Pharmacol Ther. 1975;18(2):205-209.
40. Farrell RJ, Alsahli M, Jeen Y-T, Falchuk KR, Peppercorn MA, Michetti P. Intravenous hydrocortisone premedication reduces anti- bodies to infliximab in Crohn’s disease: a randomized controlled trial. Gastroenterology. 2003;124(4):917-924.
41. Edson JR, McArthur JR, Branda RF, McCullough JJ, Chou SN. Successful man- agement of a subdural hematoma in a hemophiliac with an anti-factor VIII anti- body. Blood. 1973;41(1):113-122.
42. Montalvão SAL, Tucunduva AC, Siqueira LH, Sambo ALA, Medina SS, Ozelo MC. A longitudinal evaluation of anti-FVIII anti- bodies demonstrated IgG4 subclass is main- ly correlated with high-titre inhibitor in haemophilia A patients. Haemophilia. 2015;21(5):585-692.
43. Knowles RG, Salter M, Brooks SL MS. Anti-
inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide syn- thase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun. 1990;172 (3):1042-1048.
44. Freireich EJ, Gehan EA, Rall DP, Schmidt LH SH. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966;50(4):219-244.
45. Garbutt JM, Conlon B, Sterkel R, et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clin Pediatr (Phila). 2013;52(11):1014-1021.
46. Keeney GE, Gray MP, Morrison AK, et al. Dexamethasone for acute asthma exacerba- tions in children: a meta-analysis. Pediatrics. 2014;133(3):493-499.
47. Aljebab F, Alanazi M, Choonara I, Conroy S. Tolerability of prednisolone and dexametha- sone in Saudi Arabia. Arch Dis Child. 2016;101(9):e2.
48. Peyron I, Dimitrov JD, Delignat S, et al. Haemarthrosis and arthropathy do not favour the development of factor VIII inhibitors in severe haemophilia A mice. Haemophilia. 2015;21(1):e94-98.
49. Lövgren KM, Søndergaard H, Skov S, Wiinberg B. Joint bleeds increase the inhibitor response to human factor VIII in a rat model of severe haemophilia A. Haemophilia. 2016;22(5):772-779.
haematologica | 2018; 103(8)
1413